A Dose-Finding Study of Petrelintide With Enicepatide (RO7795068) in Adults With Obesity or Overweight
Hoffmann-La Roche · Obesity or Overweight
Phase 2
Not yet recruiting
486
2026-07
Evidence dashboardStudies since 2021Updated Jul 31, 2026
PetrelintideClinical Trials.
A source-linked view of every Petrelintide study in the current snapshot—status, phase, enrollment, results, publications, locations and changes over time.
- Total trials
- 9
- Recruiting
- 2
- Completed
- 5
- Terminated
- 0
- Results posted
- 0
- Average enrollment
- 173
- Countries
- 6
- Highest phase
- Phase 2
Largest indexed study
493 participants · NCT06662539 →Developer / research origin
Zealand Pharma
Evidence summary
Activity is not efficacy.
Petrelintide appears in 9 indexed studies: 2 recruiting, 5 completed and 0 with registry results posted. The highest registered development stage in this snapshot is Phase 2. These counts measure registry activity; they do not establish that Petrelintide is safe or effective.
Review the design, endpoints, population, protocol changes, statistical analysis and publications before drawing conclusions.
Current studies
Recruiting or active
Completed studies
Finished records
Stopped studies
Withdrawn or terminated
NCT IDStudyPhase / statusEnrollmentUpdated
Pharmacokinetics of Petrelintide in Participants With Impaired Hepatic Function
Zealand Pharma · Impaired Hepatic Function
Phase 1
Recruiting
36
2026-07
Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes (ZUPREME 2)
Zealand Pharma · Overweight · Type 2 Diabetes
Phase 2
Active, not recruiting
221
2026-01
Phase II Clinical Trial to Evaluate the Efficacy and Safety of NV01-A02 in Children With Autism Spectrum Disorder
Neuroventi Inc. · Autism Spectrum Disorder (ASD
Phase 2
Recruiting
105
2025-04
NCT IDStudyPhase / statusEnrollmentUpdated
Investigating the Pharmacokinetics of Petrelintide Using Different Drug Product Concentrations
Zealand Pharma · Obesity & Overweight
Phase 1
Completed
48
2026-04
Once-weekly Petrelintide Versus Placebo for Obesity or Overweight With Co-morbidities
Zealand Pharma · Obesity
Phase 2
Completed
493
2026-03
Pharmacokinetics of Petrelintide Following Administration to Participants With Impaired Renal Function
Zealand Pharma · Renal Impairment
Phase 1
Completed
39
2026-01
A Research Study Looking at the Safety of Multiple Doses of ZP8396 and How it Works in the Body of Healthy Participants
Zealand Pharma · Overweight · Healthy Volunteers
Phase 1
Completed
68
2024-06
A First-in-human Study Looking at the Safety of ZP8396 and How it Works in the Body of Healthy Trial Participants
Zealand Pharma · Overweight · Healthy Volunteers
Phase 1
Completed
64
2023-01
No studies in this snapshot.
Full study index
Search Petrelintide trials.
Add status, phase, condition, country, result and publication filters inside this molecule’s indexed study set.
9 matching studies
Last registry update first
Latest publications
Follow the paper trail.
No PMID-linked publications are present in the indexed registry records for this molecule.
Related pages
Keep researching Petrelintide.
Commercial research listings, where present, are kept separate from clinical evidence and are not treatment recommendations.